4//SEC Filing
Furiex Pharmaceuticals, Inc. 4
Accession 0001181431-11-059292
CIK 0001484478operating
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:32 PM ET
Size
9.4 KB
Accession
0001181431-11-059292
Insider Transaction Report
Form 4
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
- Purchase
Common Stock
2011-12-05$17.68/sh+2,850$50,388→ 2,923 total
Holdings
- 75,691
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (75,691 underlying) - 37,944
Stock Options (to buy)
Exercise: $13.16Exp: 2021-10-03→ Common Stock (37,944 underlying) - 26,000
Stock Options (to buy)
Exercise: $15.00Exp: 2021-05-09→ Common Stock (26,000 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $17.75 to $17.98. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- [F3]The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
- [F4]The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:32 PM ET
- Size
- 9.4 KB